23 employees
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.
2015
$2.5M
from 1 investors over 1 rounds
Oblique Therapeutics raised $2.5M on December 11, 2015
Investors: Almi Invest